Keyes Jeffry R. 4
4 · CNS Pharmaceuticals, Inc. · Filed Apr 10, 2024
Insider Transaction Report
Form 4
Keyes Jeffry R.
Director
Transactions
- Award
Option to purchase common stock
2024-04-08+17,500→ 62,928 totalExercise: $0.26Exp: 2034-04-08→ Common Stock (17,500 underlying) - Award
Restricted Stock Units
2024-04-08+17,500→ 80,428 total→ Common Stock (17,500 underlying)
Footnotes (3)
- [F1]The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
- [F2]The awards were issued in connection with the reporting person's Board of Director services to the Company.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Company common stock.